BRPI0817332A2 - Composição e método de ingrediente sensível estabilizado. - Google Patents

Composição e método de ingrediente sensível estabilizado.

Info

Publication number
BRPI0817332A2
BRPI0817332A2 BRPI0817332A BRPI0817332A2 BR PI0817332 A2 BRPI0817332 A2 BR PI0817332A2 BR PI0817332 A BRPI0817332 A BR PI0817332A BR PI0817332 A2 BRPI0817332 A2 BR PI0817332A2
Authority
BR
Brazil
Prior art keywords
composition
sensitive ingredient
stabilized
stabilized sensitive
ingredient
Prior art date
Application number
Other languages
English (en)
Inventor
Paul Alfred Cimiluca
Sonsoles Arnal
Jorge Zambrano
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BRPI0817332A2 publication Critical patent/BRPI0817332A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/20—Compounding polymers with additives, e.g. colouring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/0008—Organic ingredients according to more than one of the "one dot" groups of C08K5/01 - C08K5/59
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2303/00—Characterised by the use of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08J2303/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI0817332 2007-09-24 2008-09-24 Composição e método de ingrediente sensível estabilizado. BRPI0817332A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99501907P 2007-09-24 2007-09-24
US4235008P 2008-04-04 2008-04-04
PCT/IB2008/053892 WO2009040750A1 (en) 2007-09-24 2008-09-24 Composition and method of stabilized sensitive ingredient

Publications (1)

Publication Number Publication Date
BRPI0817332A2 true BRPI0817332A2 (pt) 2015-03-24

Family

ID=40336439

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0817332 BRPI0817332A2 (pt) 2007-09-24 2008-09-24 Composição e método de ingrediente sensível estabilizado.

Country Status (9)

Country Link
US (1) US9078824B2 (pt)
EP (1) EP2200590A1 (pt)
CN (1) CN101801349A (pt)
AU (1) AU2008303230B2 (pt)
BR (1) BRPI0817332A2 (pt)
CA (1) CA2700983C (pt)
MX (1) MX339598B (pt)
RU (1) RU2466741C2 (pt)
WO (1) WO2009040750A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
MX357636B (es) 2011-02-14 2018-07-17 Procter & Gamble Formas de dosificacion solidas que comprenden miel en el recubrimiento.
WO2014127118A1 (en) 2013-02-13 2014-08-21 The Procter & Gamble Company Anise flavored medication
US10799541B2 (en) 2014-07-01 2020-10-13 Probi USA, Inc. Bi-layer dual release probiotic tablets
WO2016057615A1 (en) * 2014-10-08 2016-04-14 Alva-Amco Pharmacal Companies, Inc. Composition for nap promotion
FR3047663A1 (fr) * 2016-02-12 2017-08-18 Idl Int Drug Licensing Comprime dispersible
WO2018058009A1 (en) 2016-09-26 2018-03-29 The Procter & Gamble Company Extended relief dosage form
IT202200008018A1 (it) * 2022-04-22 2023-10-22 Calliero S P A Processo per la polverizzazione e stabilizzazione di oli essenziali comprendenti furanodieni
CN117017932B (zh) * 2023-08-24 2024-05-24 浙江和沐康医药科技有限公司 一种舒林酸片组合物及其制备方法和应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453368A (en) * 1966-01-13 1969-07-01 Hoffmann La Roche Smaller high potency compressed tablets of ascorbic acid
US3480185A (en) * 1966-06-20 1969-11-25 Johnson & Johnson Charged effervescing agent and medicament dispensing metering valve-actuated aerosol container producing a dose of medicament and carbonation in water
US4820522A (en) 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
DK0587744T3 (da) 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US5674522A (en) * 1993-10-07 1997-10-07 Mcneil-Ppc, Inc. Beverage concentrate for drug delivery
US6210714B1 (en) * 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
JPH08325145A (ja) 1995-05-26 1996-12-10 Sumitomo Pharmaceut Co Ltd 安定なイソプロピルアンチピリン含有製剤
ATE277739T1 (de) 1996-10-28 2004-10-15 Gen Mills Inc Einbettung und einkapselung von teilchen zur kontrollierten abgabe
JP4384278B2 (ja) 1998-05-26 2009-12-16 東亜薬品株式会社 イブプロフェン含有粒剤
US6410052B1 (en) 1999-03-30 2002-06-25 Purdue Research Foundation Tea catechins in sustained release formulations as cancer specific proliferation inhibitors
CA2371940C (en) * 1999-03-31 2008-07-15 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6787164B2 (en) * 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US20010043959A1 (en) * 2000-02-23 2001-11-22 Daniel Gelber Composition and method for treating the effects of diseases and maladies
JP2001261580A (ja) 2000-03-14 2001-09-26 Taisho Pharmaceut Co Ltd 用時溶解型医薬
US8282955B2 (en) * 2001-10-15 2012-10-09 Ferring B.V. Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease
RU2286156C2 (ru) * 2001-10-15 2006-10-27 Ферринг Бв Способ приготовления фармацевтической композиции, включающей в себя 5-аминосалициловую кислоту, для применения в лечении неспецифического язвенного колита и болезни крона
GB0206861D0 (en) * 2002-03-22 2002-05-01 Glaxo Group Ltd Medicaments
AU2003219348A1 (en) 2002-04-22 2003-11-03 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
AR040680A1 (es) 2002-07-25 2005-04-13 Pharmacia Corp Composicion de tabletas de liberacion sostenida
JP4373649B2 (ja) 2002-08-01 2009-11-25 ロート製薬株式会社 経口用液剤
US20040101494A1 (en) * 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US20050232987A1 (en) * 2004-03-12 2005-10-20 Viswanathan Srinivasan Dosage form containing a morphine derivative and another drug
DE10359790A1 (de) 2003-12-19 2005-07-21 Bayer Healthcare Ag Brausezubereitung einer basischen arzneilich wirksamen Substanz
GB0330009D0 (en) 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
WO2006022996A2 (en) 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Dosage form containing multiple drugs
EP1874275A1 (en) * 2004-12-13 2008-01-09 McNEIL-PPC, INC. Compositons and methods for stabilizing active pharmaceutical ingredients
EP1835886A1 (en) * 2004-12-23 2007-09-26 Warner-Lambert Company LLC Orally disintegrating pharmaceutical compositions with sensory cue agents
CN1679525A (zh) * 2005-01-12 2005-10-12 复旦大学 复方对乙酰氨基酚口腔崩解片
US7851006B2 (en) * 2005-05-23 2010-12-14 Cadbury Adams Usa Llc Taste potentiator compositions and beverages containing same
EP1757274B1 (de) 2005-08-08 2012-07-25 Stada Arzneimittel Ag Brausezubereitung gegen Erkältungssymptome
CN1732938A (zh) * 2005-08-31 2006-02-15 上海医药(集团)有限公司 复方对乙酰氨基酚口腔崩解片
US20070141147A1 (en) * 2005-12-21 2007-06-21 Auriga Laboratories, Inc. Sequential release pharmaceutical formulations
US20070160695A1 (en) * 2006-01-09 2007-07-12 Clouatre Dallas L Pharmaceutical preparations for treating hypertension and dyslipidemia with Allium ursinum and Allium sativum
CA2671197A1 (en) * 2006-07-21 2008-01-24 Lab International Srl Hydrophobic abuse deterrent delivery system
US8323695B2 (en) * 2007-08-13 2012-12-04 Mcneil-Ppc, Inc. Method for stabilizing phenylephrine

Also Published As

Publication number Publication date
EP2200590A1 (en) 2010-06-30
US9078824B2 (en) 2015-07-14
CN101801349A (zh) 2010-08-11
RU2466741C2 (ru) 2012-11-20
MX2010003250A (es) 2010-04-09
MX339598B (es) 2016-06-01
CA2700983C (en) 2013-07-30
AU2008303230B2 (en) 2014-07-03
AU2008303230A1 (en) 2009-04-02
US20090082316A1 (en) 2009-03-26
CA2700983A1 (en) 2009-04-02
WO2009040750A1 (en) 2009-04-02
RU2010106225A (ru) 2011-11-10

Similar Documents

Publication Publication Date Title
BRPI0817332A2 (pt) Composição e método de ingrediente sensível estabilizado.
BRPI0917358A2 (pt) formulação farmacêutica de liberação controlada e método.
BRPI0906980A2 (pt) Composição de derivados e maleatados
DK3136030T3 (da) Fremgangsmåde til lyofilisering
BRPI0906962A2 (pt) Composto, e, composição farmacêutica
BRPI0906556A2 (pt) Composto, e, composição farmacêutica
BRPI0809573A8 (pt) composição, e, método
BRPI0922440A2 (pt) dispositivo protético e método de fabricação do mesmo .
BRPI0815588A2 (pt) Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano
BRPI0920284A2 (pt) composição e método
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
DOP2010000044A (es) Derivado de oxopirazina y herbicida
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0819232A2 (pt) composto heterocíclico e composição farmacêutica do mesmo
BRPI0823277A2 (pt) Composição, e , método
BRPI0917681A2 (pt) Composto, e, composição farmacêutica
DK2254873T3 (da) Benzodiazepinforbindelse og farmaceutisk sammensætning.
BRPI0814167A2 (pt) Composição, e, método
BRPI0807078A2 (pt) Composto, e, formulação farmacêutica
BRPI0815770A2 (pt) Composto de organoenxofre contendo flúor e composição pesticida do mesmo
BRPI0817844A2 (pt) Derivados de 3-alcóxi-1-fenilpirazol e pesticidas
BRPI0823238A2 (pt) Composição, e, método
BRPI0814748A2 (pt) Compostos de alditóis substituídos, composições e métodos
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
BRPI0719228A2 (pt) Composição estabilizada de prostaglandina e

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL